financetom
Business
financetom
/
Business
/
Beyond's Q2 Loss Narrows, Revenue Falls; Shares Rise After Hours
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Beyond's Q2 Loss Narrows, Revenue Falls; Shares Rise After Hours
Jul 29, 2024 2:54 PM

05:32 PM EDT, 07/29/2024 (MT Newswires) -- Beyond (BYON) reported a Q2 net loss late Monday of $0.93 per diluted share, compared with the loss of $1.63 a year earlier.

Analysts polled by Capital IQ expected an $0.80 loss.

Net revenue in the quarter ended June 30 fell to $398.1 million from $422.2 million a year earlier.

Analysts surveyed by Capital IQ expected $382 million.

The company's shares rose 8.3% in after-hours activity.

Price: 14.72, Change: +1.13, Percent Change: +8.31

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
--Amazon Says Tariff Price Listings Never Considered for Main Website, Washington Post Reports
--Amazon Says Tariff Price Listings Never Considered for Main Website, Washington Post Reports
May 25, 2025
10:30 AM EDT, 04/29/2025 (MT Newswires) -- Price: 185.62, Change: -2.08, Percent Change: -1.11 ...
Billionaire investor John Paulson sees gold near $5,000 by 2028
Billionaire investor John Paulson sees gold near $5,000 by 2028
May 25, 2025
April 29 (Reuters) - Central bank gold buying and global trade tensions are likely to push bullion prices to near $5,000 an ounce by 2028, billionaire investor John Paulson said in an interview during which he reinforced his commitment to U.S. mining projects The price forecast is one of the most bullish yet as banks and others move to increase...
AstraZeneca Halts Phase 3 Trial for Prostate Cancer Treatment Combination
AstraZeneca Halts Phase 3 Trial for Prostate Cancer Treatment Combination
May 25, 2025
10:27 AM EDT, 04/29/2025 (MT Newswires) -- AstraZeneca ( AZN ) halted its phase 3 trial for prostate cancer treatment Truqap based on the recommendation of an independent data monitoring committee. The trial, which evaluated the efficacy and safety of Truqap in combination with docetaxel and androgen-deprivation therapy in patients with metastatic castration-resistant prostate cancer, was deemed unlikely to achieve...
Google agrees $36 million fine for anti-competitive deals with Australia telcos
Google agrees $36 million fine for anti-competitive deals with Australia telcos
Aug 17, 2025
SYDNEY, Aug 18 (Reuters) - Google agreed on Monday to pay a A$55 million ($35.8 million) fine in Australia after the consumer watchdog found it had hurt competition by paying the country's two largest telcos to pre-install its search application on Android phones, excluding rival search engines. The fine extends a bumpy period for the Alphabet-owned internet giant in Australia,...
Copyright 2023-2026 - www.financetom.com All Rights Reserved